[5-min read] Q&A with Rhonda DeSantis, Founder & Cultivator
[3-min read] Facilitators explain how neurodivergence shapes psychedelic journeys.
[5-min read] Researchers conduct first trial of MDMA-assisted therapy for depression.
[5-min read] Q&A with Sabba Nazhand, Founder & CEO
[3-min read] Psychedelic facilitators explain how to support a friend through their own integration.
[5-min read] DEA announces steep production quota increases for multiple psychedelics.
[5-min read] Q&A with Manoj Doss, Cognitive Neuroscientist
[3-min read] Psychedelic facilitators explain how to choose between low and high doses.
[5-min read] Study finds psychedelic decriminalization hasn't increased ER visits.
[5-min read] Q&A with Crystal C. Romero, Veteran & Advocate
[3-min read] Facilitators are split on combining bodywork with psychedelics.
[5-min read] AtaiBeckley posts open-label extension results for its 5-MeO-DMT formulation.
